1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Instrument
1.2.3 Reagent
1.2.4 Other
1.3 Market by Application
1.3.1 Global Liquid Biopsy Diagnostic Tool Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Third-party Testing Agency
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Liquid Biopsy Diagnostic Tool Market Perspective (2017-2028)
2.2 Liquid Biopsy Diagnostic Tool Growth Trends by Region
2.2.1 Liquid Biopsy Diagnostic Tool Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Liquid Biopsy Diagnostic Tool Historic Market Size by Region (2017-2022)
2.2.3 Liquid Biopsy Diagnostic Tool Forecasted Market Size by Region (2023-2028)
2.3 Liquid Biopsy Diagnostic Tool Market Dynamics
2.3.1 Liquid Biopsy Diagnostic Tool Industry Trends
2.3.2 Liquid Biopsy Diagnostic Tool Market Drivers
2.3.3 Liquid Biopsy Diagnostic Tool Market Challenges
2.3.4 Liquid Biopsy Diagnostic Tool Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Liquid Biopsy Diagnostic Tool Players by Revenue
3.1.1 Global Top Liquid Biopsy Diagnostic Tool Players by Revenue (2017-2022)
3.1.2 Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Players (2017-2022)
3.2 Global Liquid Biopsy Diagnostic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Biopsy Diagnostic Tool Revenue
3.4 Global Liquid Biopsy Diagnostic Tool Market Concentration Ratio
3.4.1 Global Liquid Biopsy Diagnostic Tool Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Biopsy Diagnostic Tool Revenue in 2021
3.5 Liquid Biopsy Diagnostic Tool Key Players Head office and Area Served
3.6 Key Players Liquid Biopsy Diagnostic Tool Product Solution and Service
3.7 Date of Enter into Liquid Biopsy Diagnostic Tool Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Liquid Biopsy Diagnostic Tool Breakdown Data by Type
4.1 Global Liquid Biopsy Diagnostic Tool Historic Market Size by Type (2017-2022)
4.2 Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Type (2023-2028) 5 Liquid Biopsy Diagnostic Tool Breakdown Data by Application
5.1 Global Liquid Biopsy Diagnostic Tool Historic Market Size by Application (2017-2022)
5.2 Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Liquid Biopsy Diagnostic Tool Market Size (2017-2028)
6.2 North America Liquid Biopsy Diagnostic Tool Market Size by Country (2017-2022)
6.3 North America Liquid Biopsy Diagnostic Tool Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Liquid Biopsy Diagnostic Tool Market Size (2017-2028)
7.2 Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2017-2022)
7.3 Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size (2017-2028)
8.2 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Country (2017-2022)
8.3 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Liquid Biopsy Diagnostic Tool Market Size (2017-2028)
9.2 Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2017-2022)
9.3 Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size (2017-2028)
10.2 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2017-2022)
10.3 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Detail
11.1.2 Biocept Business Overview
11.1.3 Biocept Liquid Biopsy Diagnostic Tool Introduction
11.1.4 Biocept Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.1.5 Biocept Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Liquid Biopsy Diagnostic Tool Introduction
11.2.4 Qiagen Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.2.5 Qiagen Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Liquid Biopsy Diagnostic Tool Introduction
11.3.4 Roche Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.3.5 Roche Diagnostics Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Introduction
11.4.4 Bio-Rad Laboratories Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Detail
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Liquid Biopsy Diagnostic Tool Introduction
11.5.4 Myriad Genetics Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.5.5 Myriad Genetics Recent Development
11.6 Menarini-Silicon Biosystems
11.6.1 Menarini-Silicon Biosystems Company Detail
11.6.2 Menarini-Silicon Biosystems Business Overview
11.6.3 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Introduction
11.6.4 Menarini-Silicon Biosystems Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.6.5 Menarini-Silicon Biosystems Recent Development
11.7 Trovagene
11.7.1 Trovagene Company Detail
11.7.2 Trovagene Business Overview
11.7.3 Trovagene Liquid Biopsy Diagnostic Tool Introduction
11.7.4 Trovagene Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.7.5 Trovagene Recent Development
11.8 Guardant Health
11.8.1 Guardant Health Company Detail
11.8.2 Guardant Health Business Overview
11.8.3 Guardant Health Liquid Biopsy Diagnostic Tool Introduction
11.8.4 Guardant Health Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.8.5 Guardant Health Recent Development
11.9 Mdxhealth
11.9.1 Mdxhealth Company Detail
11.9.2 Mdxhealth Business Overview
11.9.3 Mdxhealth Liquid Biopsy Diagnostic Tool Introduction
11.9.4 Mdxhealth Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.9.5 Mdxhealth Recent Development
11.10 Genomic Health
11.10.1 Genomic Health Company Detail
11.10.2 Genomic Health Business Overview
11.10.3 Genomic Health Liquid Biopsy Diagnostic Tool Introduction
11.10.4 Genomic Health Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.10.5 Genomic Health Recent Development
11.11 Raindance Technologies
11.11.1 Raindance Technologies Company Detail
11.11.2 Raindance Technologies Business Overview
11.11.3 Raindance Technologies Liquid Biopsy Diagnostic Tool Introduction
11.11.4 Raindance Technologies Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.11.5 Raindance Technologies Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Introduction
11.12.4 Thermo Fisher Scientific Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Illumina
11.13.1 Illumina Company Detail
11.13.2 Illumina Business Overview
11.13.3 Illumina Liquid Biopsy Diagnostic Tool Introduction
11.13.4 Illumina Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.13.5 Illumina Recent Development
11.14 Amoy Diagnostics
11.14.1 Amoy Diagnostics Company Detail
11.14.2 Amoy Diagnostics Business Overview
11.14.3 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Introduction
11.14.4 Amoy Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.14.5 Amoy Diagnostics Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Detail
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Liquid Biopsy Diagnostic Tool Introduction
11.15.4 Johnson & Johnson Revenue in Liquid Biopsy Diagnostic Tool Business (2017-2022)
11.15.5 Johnson & Johnson Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
